News
WST
331.40
+1.34%
4.39
Looking Into West Pharmaceutical Servs's Recent Short Interest
Benzinga · 18h ago
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now
NASDAQ · 23h ago
Analysts Expect VOO To Hit $606
NASDAQ · 23h ago
Weekly Report: what happened at WST last week (1209-1213)?
Weekly Report · 5d ago
How Is West Pharmaceutical Services' Stock Performance Compared to Other Medical Devices Stocks?
Barchart · 5d ago
West Pharmaceutical Services to Buy Back Up To 550,000 Shares
Dow Jones · 12/13 21:23
West Pharmaceutical announces 550,000 share repurchase program
TipRanks · 12/13 21:10
West Pharma Is Maintained at Buy by B of A Securities
Dow Jones · 12/13 16:15
West Pharma Price Target Raised to $355.00/Share From $350.00 by B of A Securities
Dow Jones · 12/13 16:15
B of A Securities Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $355
Benzinga · 12/13 16:04
West Pharma Initiated at Peer Perform by Wolfe Research
Dow Jones · 12/13 14:21
Wolfe Research Initiates Coverage On West Pharmaceutical Servs with Peer Perform Rating
Benzinga · 12/13 14:11
West Pharmaceutical price target raised to $355 from $350 at BofA
TipRanks · 12/13 13:16
West Pharmaceutical initiated with a Peer Perform at Wolfe Research
TipRanks · 12/13 11:01
West Pharma Raised to Buy From Neutral by UBS
Dow Jones · 12/12 16:20
West Pharma Price Target Raised to $390.00/Share From $350.00 by UBS
Dow Jones · 12/12 16:20
UBS Upgrades West Pharmaceutical Servs to Buy, Raises Price Target to $390
Benzinga · 12/12 16:10
West Pharmaceutical upgraded to Buy from Neutral at UBS
TipRanks · 12/12 13:00
West Pharmaceutical Expands Board with New Director
TipRanks · 12/11 21:32
*West Elects Janet Haugen to the Bd of Directors
Dow Jones · 12/11 11:01
More
Webull provides a variety of real-time WST stock news. You can receive the latest news about West Pharm Svcs through multiple platforms. This information may help you make smarter investment decisions.
About WST
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers packaging, containment solutions, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.